Project Details
Description
Efficacy and Safety of 3 Week fixed Dose Asenpine Treatment in Pediatric Acute Manic or Mixed Episodes Associated with BP1 disorder #PO6107
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/12 → 11/28/12 |
Funding
- SCHERING-PLOUGH CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.